Full Press Release Details
Conference Call Scheduled for 8am Eastern Time
TEL AVIV, Israel, Oct. 30, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, November 6, 2018, to discuss financial results for the three and nine months ended September 30, 2018, and provide a corporate update.
| Conference Call & Webcast: | ||
| Tuesday, November 6 @ 8:00am Eastern Time | ||
| Within the US: | 877-451-6152 | |
| Outside the US: | 201-389-0879 | |
| Conference ID: | 13683949 | |
| Webcast: | http://public.viavid.com/index.php?id=131700 | |
| Replays, Available through November 20: | ||
| Domestic: | 844-512-2921 | |
| International: | 412-317-6671 | |
| Replay PIN: | 13683949 |
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.